Pazonib (Pazopanib) 200mg*30 | DIL Bangladesh Generic | GLT

Generic Information: Pazonib (Pazopanib) 200mg — Bangladesh

Pazonib is a Bangladesh-manufactured generic of pazopanib produced by Drug International Limited (DIL), a well-established Bangladeshi pharmaceutical company. The product is supplied as 200 mg film-coated tablets in 30-tablet packs, matching the originator's standard strength. Pazonib is DIL's pazopanib brand for advanced renal cell carcinoma and soft tissue sarcoma, offering patients in South Asia and beyond an affordable alternative to the high-priced originator.

Bangladesh has a mature generic pharmaceutical industry that supplies much of the developing world, and Drug International Limited is a recognised name within it. Because pazopanib is taken at 800 mg once daily (four 200 mg tablets), buyers should account for the tablet count when planning a monthly supply.

What Is Pazonib Used For?

Pazonib is prescribed for advanced renal cell carcinoma (RCC) in the first-line setting and after prior cytokine therapy, and for advanced soft tissue sarcoma (STS) in patients who have received prior chemotherapy. Pazopanib's anti-angiogenic mechanism is the basis of its activity in these vascular-driven cancers.

How Does Pazonib Work?

Pazopanib, the active ingredient in Pazonib, is a multi-targeted tyrosine kinase inhibitor that blocks vascular endothelial growth factor receptors (VEGFR-1, -2, -3), platelet-derived growth factor receptors (PDGFR-α, -β) and c-Kit. By inhibiting these kinases, Pazonib disrupts tumour angiogenesis, reducing the blood supply that growing tumours depend on and slowing their progression.

Indications

• Advanced renal cell carcinoma (RCC), first-line and after prior cytokine therapy.
• Advanced soft tissue sarcoma (STS) in patients who have received prior chemotherapy.

Dosage and Administration

The recommended dose is 800 mg once daily, taken as four 200 mg tablets on an empty stomach (at least 1 hour before or 2 hours after a meal), swallowed whole. A 30-tablet pack provides about one week of therapy. Dose adjustment is required for hepatic impairment, and liver function and blood pressure are monitored during treatment.

Side Effects

Common adverse reactions include diarrhoea, hypertension, hair colour changes, nausea, fatigue, decreased appetite and vomiting. Pazopanib carries a boxed warning for severe hepatotoxicity, so liver function must be monitored before and during therapy. Hypothyroidism, haemorrhage and QT prolongation may also occur, and patients should report yellowing, unusual bleeding or palpitations.

Storage

Store Pazonib below 30°C in the original pack, away from moisture and out of the reach of children. Use before the expiry date printed on the pack.

Why Choose the GLT?

GLT sources Pazonib through an audited Bangladesh-based supply chain and documents every batch, which matters for buyers who need a dependable, traceable generic alternative to the high-priced originator. Compared with the US list price of branded pazopanib, Bangladesh and other regional generics typically cost a small fraction — often several times lower — making long-term anti-angiogenic therapy far more sustainable. We provide clear purchase documentation and direct contact for ongoing support.

How to Order Pazonib from GLT

To order Pazonib 200 mg (30 tablets), contact GLT on WhatsApp at +86 15234153837 or email [email protected]. Tell us your quantity, shipping destination and whether you require a prescription or purchase order. We confirm batch details and lead time before dispatch.

FAQ

Is Pazonib the same as Votrient? Pazonib contains the same active ingredient (pazopanib) at the same 200 mg strength as Votrient; it is a generic manufactured in Bangladesh by Drug International Limited.

What is the standard dose? 800 mg once daily (four 200 mg tablets), taken on an empty stomach.

Where can I order Pazonib? GLT can supply Pazonib internationally; contact us on WhatsApp or email for availability.